This trial is testing a lower-dose SBRT regimen for tumors in the chest.
2 Primary · 5 Secondary · Reporting Duration: Up to 10 years post-enrollment.
Experimental Treatment
60 Total Participants · 1 Treatment Group
Primary Treatment: 45 Gray (Gy) regimen · No Placebo Group · Phase 1 & 2
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: